Medi-Caps Limited filed a regulatory disclosure pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 regarding key management appointments approved by the Board of Directors.

The Board meeting commenced at 3:00 PM and concluded at 3:55 PM on August 6, 2026.

Key Appointments Approved:

1. Re-appointment of Mr. Alok K. Garg (DIN: 00274321)

  • Position: Chairman Cum Managing Director
  • Term: Three years from 01st September, 2026 to 31st August, 2029
  • Status: Subject to approval of members at the ensuing 43rd Annual General Meeting
  • Profile: Mr. Garg holds a Master's in Business Administration (Marketing) and a Diploma in Export Documentation & Implementation from The Indian Institute of Foreign Trade, Delhi. He has over 26 years' experience in branding, marketing, and organizational development.

2. Appointment of Mr. Akshit Garg

  • Position: Chief Financial Officer (CFO) and Key Managerial Personnel (KMP)
  • Effective Date: 07th August, 2026 (immediate effect)
  • Profile: Mr. Akshit Garg holds a Master's in Management and Finance from Royal Melbourne Institute of Technology, Australia. He has over 8 years of experience in Finance and Marketing.

3. Appointment of Mrs. Saloni Garg (DIN: 11865402)

  • Position: Additional Director and Whole Time Woman Director
  • Term: Three years from 07th August, 2026 to 06th August, 2029
  • Status: Subject to approval of members at the ensuing 43rd Annual General Meeting
  • Profile: Mrs. Saloni Garg holds a Graduate degree in Business Management from Mumbai. She is a management professional with strong academic background in business and brand strategy, and is already associated with Medi-Caps Limited as senior manager.

Relationships Between Directors:

  • Mr. Alok K. Garg is the father-in-law of Mrs. Saloni Garg
  • Mrs. Saloni Garg is the daughter-in-law of Mr. Alok K. Garg

Regulatory Compliance Confirmation:

The company confirmed that both Mr. Alok K Garg and Mrs. Saloni Garg are not debarred from holding office of Director by virtue of any SEBI order or any other authority. No authority has passed any order restricting their ability to act as Directors of the Company.

The disclosure was made in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-PoD2/I/3762/2026 dated January 30, 2026, with detailed information provided in Annexure-A.

The company will also submit the disclosure in the prescribed XBRL format along with the PDF submission, and the information will be available on the company website at www.medicaps.com.